Suppr超能文献

尿激酶型纤溶酶原激活剂/其可溶性受体系统与颈动脉粥样硬化独立相关,并与尿毒症患者的CC趋化因子有关。

The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.

作者信息

Pawlak Krystyna, Mysliwiec Michal, Pawlak Dariusz

机构信息

Department of Monitored Pharmacotherapy, Medical University of Bialystok, Mickiewicza 2C Street, 15-089 Bialystok, Poland.

出版信息

Thromb Res. 2008;122(3):328-35. doi: 10.1016/j.thromres.2007.10.017. Epub 2007 Nov 28.

Abstract

INTRODUCTION

The urokinase-type plasminogen activator (uPA)/its soluble receptor (suPAR) and CC-chemokines are two systems contributing in the atherosclerosis. We try to establish whether these two systems were associated among themselves, and the significance of this potential association in relation to carotid atherosclerosis in uraemic patients.

MATERIALS AND METHODS

We determined uPA, suPAR, CC-chemokines: monocyte chemoattractant protein-1 (CCL2), macrophage inflammatory proteins (CCL3, CCL4), regulated upon activation, normal T cell expressed and secreted (CCL5) and the intima-media thickness (IMT) values in uraemic patients on peritoneal dialysis (CAPD), haemodialysis (HD) and healthy controls.

RESULTS

The values of the uPA/suPAR system, CCL2, CCL4 and IMT in the patients significantly exceeded those in controls, whereas CCL5 were lower in the patients than in the controls. CCL3 concentrations were similar in all investigated groups. CCL2, CCL4 and CCL5 were positively associated with uPA/suPAR system. CCL2 and CCL4 were associated with IMT. Multivariate analysis showed that uPA, suPAR and age were the strong independent variables linked to IMT values.

CONCLUSIONS

The carotid atherosclerosis is independently related to uPA/its soluble receptor system in dialysis patients. In addition, the strong positive associations existed between uPA/suPAR system and CC-chemokines suggesting that these two systems could cooperate and influence of atherosclerosis in these patients.

摘要

引言

尿激酶型纤溶酶原激活剂(uPA)/其可溶性受体(suPAR)和CC趋化因子是在动脉粥样硬化中起作用的两个系统。我们试图确定这两个系统之间是否相互关联,以及这种潜在关联在尿毒症患者颈动脉粥样硬化方面的意义。

材料与方法

我们测定了尿毒症腹膜透析(CAPD)患者、血液透析(HD)患者及健康对照者的uPA、suPAR、CC趋化因子:单核细胞趋化蛋白-1(CCL2)、巨噬细胞炎性蛋白(CCL3、CCL4)、活化后正常T细胞表达和分泌因子(CCL5)以及内膜中层厚度(IMT)值。

结果

患者的uPA/suPAR系统、CCL2、CCL4及IMT值显著高于对照组,而患者的CCL5低于对照组。所有研究组的CCL3浓度相似。CCL2、CCL4及CCL5与uPA/suPAR系统呈正相关。CCL2和CCL4与IMT相关。多变量分析显示uPA、suPAR和年龄是与IMT值相关的强独立变量。

结论

在透析患者中,颈动脉粥样硬化与uPA/其可溶性受体系统独立相关。此外,uPA/suPAR系统与CC趋化因子之间存在强正相关,提示这两个系统可能协同作用并影响这些患者的动脉粥样硬化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验